1. Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients.
- Author
-
Join-Lambert O, Duchatelet S, Delage M, Miskinyte S, Coignard H, Lemarchand N, Alemy-Carreau M, Lortholary O, Nassif X, Hovnanian A, and Nassif A
- Subjects
- Acne Vulgaris complications, Acne Vulgaris diagnosis, Acne Vulgaris surgery, Adult, Combined Modality Therapy, Female, Follow-Up Studies, Hidradenitis Suppurativa complications, Hidradenitis Suppurativa diagnosis, Hidradenitis Suppurativa surgery, Humans, Male, Microbiota drug effects, Pyoderma Gangrenosum complications, Pyoderma Gangrenosum diagnosis, Pyoderma Gangrenosum surgery, Sampling Studies, Severity of Illness Index, Skin drug effects, Skin microbiology, Syndrome, Treatment Outcome, Young Adult, Acne Vulgaris drug therapy, Anti-Bacterial Agents therapeutic use, Drug Delivery Systems methods, Hidradenitis Suppurativa drug therapy, Pyoderma Gangrenosum drug therapy
- Abstract
Pyoderma gangrenosum, severe acne, and suppurative hidradenitis (PASH) syndrome can prove refractory to treatment and is characterized by relapses and recurrences. The combination of antibiotic therapy and surgery can produce success in the management of the syndrome. Acute treatment is required, but maintenance therapy is also necessary to prevent disease relapse. The response to antibiotic therapy is hypothesis generating, raising the issue of a modified host response. To date, anecdotal reports support the use of surgery and medical therapy, but controlled investigations with extended follow-up are necessary to substantiate preliminary data observed with individual cases., (Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF